UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

Molecular Drivers of Myelodysplastic Neoplasms (MDS)-Classification and Prognostic Relevance

Cells (Basel, Switzerland), 2023-02, Vol.12 (4), p.627

2023

Link zum Volltext

Verfügbarkeit prüfen

Prognostication of DNA Damage Response Protein Expression Patterns in Chronic Lymphocytic Leukemia

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5481

2023

Link zum Volltext

Verfügbarkeit prüfen

DNA Damage Response-Related Proteins Are Prognostic for Outcome in Both Adult and Pediatric Acute Myelogenous Leukemia Patients: Samples from Adults and from Children Enrolled in a Children's Oncology Group Study

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5898

2023

Link zum Volltext

Verfügbarkeit prüfen

Reverse Phase Protein Array Profiling Identifies Recurrent Protein Expression Patterns of DNA Damage-Related Proteins across Acute and Chronic Leukemia: Samples from Adults and the Children's Oncology Group

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5460

2023

Link zum Volltext

Verfügbarkeit prüfen

Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis

Blood cancer journal (New York), 2024-03, Vol.14 (1), p.52-8, Article 52

2024

Link zum Volltext

Verfügbarkeit prüfen

RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit

Oncotarget, 2020-06, Vol.11 (25), p.2387-2403

2020

Link zum Volltext

Verfügbarkeit prüfen

Valosin‐containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group

Proteomics. Clinical applications, 2023-11, Vol.17 (6), p.e2200109-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets

Blood cancer journal (New York), 2022-03, Vol.12 (3), p.43-43, Article 43

2022

Link zum Volltext

Verfügbarkeit prüfen

Protein profiling by reverse phase protein array (RPPA) in classical hairy cell leukemia (HCL) and HCL‐variant

EJHaem, 2022-11, Vol.3 (4), p.1321-1325

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome of progressive multifocal leukoencephalopathy with recombinant interleukin-2 treatment and an associated increase in the number of HPyV-2-specific T-cells: a case report

Therapeutic advances in hematology, 2023-01, Vol.14

2023

Link zum Volltext

Verfügbarkeit prüfen

The mitochondrial peptidase, neurolysin, regulates respiratory chain supercomplex formation and is necessary for AML viability

Science translational medicine, 2020-04, Vol.12 (538)

2020

Link zum Volltext

Verfügbarkeit prüfen

Real-world outcomes of frontline venetoclax-based therapy in older adults with acute myeloid leukemia: an analysis utilizing EHR data

Leukemia & lymphoma, 2023-05, Vol.64 (6), p.1123-1128

2023

Link zum Volltext

Verfügbarkeit prüfen

Reverse phase protein arrays in acute leukemia: investigative and methodological challenges

Expert review of proteomics, 2021-12, Vol.18 (12), p.1087-1097

2021

Link zum Volltext

Verfügbarkeit prüfen

BTK inhibition sensitizes acute lymphoblastic leukemia to asparaginase by suppressing the amino acid response pathway

Blood, 2021-12, Vol.138 (23), p.2383-2395

2021

Link zum Volltext

Verfügbarkeit prüfen

Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report

Blood, 2021-02, Vol.137 (8), p.1050-1060

2021

Link zum Volltext

Verfügbarkeit prüfen

RPPA-based proteomics recognizes distinct epigenetic signatures in chronic lymphocytic leukemia with clinical consequences

Leukemia, 2022-03, Vol.36 (3), p.712-722

2022

Link zum Volltext

Verfügbarkeit prüfen

Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF‐κB subunit RelA

Proteomics (Weinheim), 2022-03, Vol.16 (2), p.e2100072-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Post-transplant cyclophosphamide and early mixed donor Chimerism in myeloid malignancies; a single-center experience

Transplant immunology, 2023-04, Vol.77, p.101808-101808, Article 101808

2023

Link zum Volltext

Verfügbarkeit prüfen

The effects of sample handling on proteomics assessed by reverse phase protein arrays (RPPA): Functional proteomic profiling in leukemia

Journal of proteomics, 2021-02, Vol.233, p.104046-104046, Article 104046

2021

Link zum Volltext

Verfügbarkeit prüfen

Recognition of Recurrent Protein Expression Patterns in Pediatric Acute Myeloid Leukemia Identified New Therapeutic Targets

Molecular cancer research, 2018-08, Vol.16 (8), p.1275-1286

2018

Link zum Volltext

Verfügbarkeit prüfen

Histone Modification Patterns Using RPPA‐Based Profiling Predict Outcome in Acute Myeloid Leukemia Patients

Proteomics (Weinheim), 2018-04, Vol.18 (8), p.e1700379-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Early‐onset diabetes mellitus as a presenting feature of Werner's syndrome in an Indian family

Molecular genetics & genomic medicine, 2024-01, Vol.12 (1), p.e2299-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Recurrent Patterns of Protein Expression Signatures in Pediatric Acute Lymphoblastic Leukemia: Recognition and Therapeutic Guidance

Molecular cancer research, 2018-08, Vol.16 (8), p.1263-1274

2018

Link zum Volltext

Verfügbarkeit prüfen

Antibody Screening

Advances in experimental medicine and biology, 2019, Vol.1188, p.149-163

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Englisch
(61)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Molecular Drivers of Myelodysplastic Neoplasms (MDS)-Classification and Prognostic Relevance

Prognostication of DNA Damage Response Protein Expression Patterns in Chronic Lymphocytic Leukemia

DNA Damage Response-Related Proteins Are Prognostic for Outcome in Both Adult and Pediatric Acute Myelogenous Leukemia Patients: Samples from Adults and from Children Enrolled in a Children's Oncology Group Study

Reverse Phase Protein Array Profiling Identifies Recurrent Protein Expression Patterns of DNA Damage-Related Proteins across Acute and Chronic Leukemia: Samples from Adults and the Children's Oncology Group

Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis

RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit

Valosin‐containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group

Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets

Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial

Protein profiling by reverse phase protein array (RPPA) in classical hairy cell leukemia (HCL) and HCL‐variant

Long-term outcome of progressive multifocal leukoencephalopathy with recombinant interleukin-2 treatment and an associated increase in the number of HPyV-2-specific T-cells: a case report

The mitochondrial peptidase, neurolysin, regulates respiratory chain supercomplex formation and is necessary for AML viability

Real-world outcomes of frontline venetoclax-based therapy in older adults with acute myeloid leukemia: an analysis utilizing EHR data

Reverse phase protein arrays in acute leukemia: investigative and methodological challenges

BTK inhibition sensitizes acute lymphoblastic leukemia to asparaginase by suppressing the amino acid response pathway

Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report

RPPA-based proteomics recognizes distinct epigenetic signatures in chronic lymphocytic leukemia with clinical consequences

Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF‐κB subunit RelA

Post-transplant cyclophosphamide and early mixed donor Chimerism in myeloid malignancies; a single-center experience

The effects of sample handling on proteomics assessed by reverse phase protein arrays (RPPA): Functional proteomic profiling in leukemia

Recognition of Recurrent Protein Expression Patterns in Pediatric Acute Myeloid Leukemia Identified New Therapeutic Targets

Histone Modification Patterns Using RPPA‐Based Profiling Predict Outcome in Acute Myeloid Leukemia Patients

Early‐onset diabetes mellitus as a presenting feature of Werner's syndrome in an Indian family

Recurrent Patterns of Protein Expression Signatures in Pediatric Acute Lymphoblastic Leukemia: Recognition and Therapeutic Guidance

Antibody Screening

Suchergebnisse filtern